Stability, speed and strategy: Inside Australia’s early‑stage edge

October 29, 2026 |

1 min read |

Jennifer C. Smith-Parker, BioSpace Insights

In this episode of Denatured, you’ll hear from Jerome Barley, commercial director at Avion Medical and Ryan Klein, vice president, business development, US and APAC at Resolian. We discuss why Australia has become a magnet for early clinical development, and whether its speed, regulatory clarity and tax incentives are pushing it toward a more integrated biotech role.

> Listen on Spotify
> Listen on Apple Podcasts
> Listen on Amazon Music
> Watch on YouTube

In this episode of Denatured, you’ll listen to Jerome Barley, commercial director at Avion Medical and Ryan Klein, vice president, business development, US and APAC at Resolian. We look at why Australia attracts so much early clinical work, and whether its fast timelines, clear rules and tax breaks are turning it into a core player in the biotech industry

Host

⁠Jennifer C. Smith-Parker, Director of Insights, BioSpace

Guests

Jerome Barley, Commercial Director, Avion Medical

Ryan Klein, Vice President, Business Development, US and APAC, Resolian

Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.

Podcasts BioSpace Insights Denatured Clinical research Cell therapy Gene therapy Funding FDA Regulatory Australia Tax incentives United States Preclinical Healthcare Research institute Manufacturing CRO Patient recruitment

Jennifer C. Smith-Parker

Jennifer C. Smith-Parker is Director of Insights at BioSpace. She has been been immersed for 20 years in healthcare, first as a journalist and editor before pivoting to corporate, brand, and product communications. A skilled storyteller, she is adept at creating diverse content across platforms and crafting narratives that drive engagement, strengthen reputation, and deliver measurable growth. You can reach her at Jennifer.Smith-Parker@BioSpace.com.

BioSpace Insights

The BioSpace Insights teams performs research and analysis on industry trends for BioSpace and clients, producing industry reports, podcasts, events and articles.